Peter Verhamme, MD, PhD

MD, PhD
University Hospitals Leuven, Belgium

Presentation(s):

• SS 03.4 - Hands-on Hints for Anticoagulation Reversal: Insight From Patient Cases

  Saturday, July 9, 2022
  12:25 PM – 12:45 PM

• OC 13.5 - A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study

  Sunday, July 10, 2022
  11:45 AM – 12:00 PM

• PB0098 - Long-term persistence of anti-PF4-antibodies following Vaccine-Induced Thrombotic Thrombocytopenia after first ChAdOx1 vaccination.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 34.5 - Identification of risk factors for major bleeding during anticoagulation and recurrent venous thromboembolism after its discontinuation in patients with a first unprovoked venous thromboembolism.

  Monday, July 11, 2022
  11:45 AM – 12:00 PM

• PB0666 - A new FVIII chromogenic assay with bovine FX is sensitive enough for the diagnosis of severe haemophilia A.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0762 - Ticagrelor prevents infective endocarditis by mitigating Staphylococcus aureus virulence

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0974 - Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1290 - The contribution of peptidylarginine deiminase 4 and NETs to a dysregulated VWF/ADAMTS13 axis in Staphylococcus aureus bacteremia in patients

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• LB 02.1 - Intermediate versus low-dose low-molecular-weight heparin in pregnant and postpartum women with a history of venous thromboembolism (Highlow Study)

  Wednesday, July 13, 2022
  10:15 AM – 10:30 AM

• OC 72.2 - Neutrophils protect against Staphylococcus aureus endocarditis but the impact of NET release is negated by coagulases

  Wednesday, July 13, 2022
  10:30 AM – 10:45 AM